Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to explore a more individualized treatment regime based on achievement
of disease stability to define a personal optimal treatment interval with ranibizumab in
patients with visual impairment due to diabetic macular edema.